Cargando…

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study

INTRODUCTION: Gout is a common, progressive, systemic inflammatory arthritis caused by hyperuricemia. Current guidelines recommend that serum uric acid (sUA) levels be maintained below 6.0 mg/dl to minimize acute gout attacks, tophi development, and long-term joint and organ damage. This study exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francis-Sedlak, Megan, LaMoreaux, Brian, Padnick-Silver, Lissa, Holt, Robert J., Bello, Alfonso E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991061/ https://www.ncbi.nlm.nih.gov/pubmed/33284422 http://dx.doi.org/10.1007/s40744-020-00260-1

Ejemplares similares

Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
por: Masri, Karim Richard, et al.
Publicado: (2022)

Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout
por: Broadwell, Aaron, et al.
Publicado: (2022)

Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
por: Schlesinger, Naomi, et al.
Publicado: (2022)

Comparison Between Early-Onset and Common Gout: A Systematic Literature Review
por: Amatucci, Anthony J., et al.
Publicado: (2023)

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12‐Month Findings
por: Botson, John K., et al.
Publicado: (2023)

Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study
por: Albert, John A., et al.
Publicado: (2020)

Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2021)

Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2022)

Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial
por: Botson, John K., et al.
Publicado: (2022)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
por: Morton, Allan H., et al.
Publicado: (2018)

SAT-424 Assessing Content Validity of the Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) in the United States
por: Stan, Marius N, et al.
Publicado: (2020)

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis
por: REINHARDT, Maximilian, et al.
Publicado: (2021)

A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings
por: Botson, John K., et al.
Publicado: (2022)

Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
por: Baxter, Britni, et al.
Publicado: (2023)

Comorbidity status in hospitalized elderly in Japan: Analysis from National Database of Health Insurance Claims and Specific Health Checkups
por: Nojiri, Shuko, et al.
Publicado: (2019)

The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data
por: Akari, Seigo, et al.
Publicado: (2022)

Insured Lives as Affected by Gout
por: Marsh, E. J.
Publicado: (1895)

A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study
por: Botson, John K., et al.
Publicado: (2022)

Use of and Comorbidities Associated With Diagnostic Codes for COVID-19 in US Health Insurance Claims
por: Yang, Kai-Cheng, et al.
Publicado: (2021)

The Singapore Experience With Uncontrolled Gout: Unmet Needs in the Management of Patients
por: Lee, Zheng Cong, et al.
Publicado: (2023)

Gout and comorbidity: a nominal group study of people with gout
por: Singh, Jasvinder A.
Publicado: (2017)

Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study
por: Singh, Jasvinder A., et al.
Publicado: (2017)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database
por: Kim, Ji-Won, et al.
Publicado: (2018)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany
por: Christensen, Stefan, et al.
Publicado: (2019)

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
por: Charbonnel, Bernard, et al.
Publicado: (2017)

The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
por: Cha, Yu-Jin
Publicado: (2018)

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database
por: Morikubo, Hiromu, et al.
Publicado: (2021)

Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database
por: Takagi, Akira, et al.
Publicado: (2022)

Data resource profile: JMDC claims database sourced from health insurance societies
por: Nagai, Katsuhiko, et al.
Publicado: (2021)

Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
por: Senna, Maryanne, et al.
Publicado: (2021)

Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System
por: Mikuls, Ted R., et al.
Publicado: (2022)

Cardiovascular Risks in Korean Patients with Gout: Analysis Using a National Health Insurance Service Database
por: Moon, Ki Won, et al.
Publicado: (2022)

Gout and dementia in the elderly: a cohort study of Medicare claims
por: Singh, Jasvinder A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4g09h79s22c5ugu7bjr8pq3s9d